Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) von Coleman, R.E., Collinson, M., Gregory, W., Marshall, H., Bell, R., Dodwell, D., Keane, M., Gil, M., Barrett-Lee, P., Ritchie, D., Bowman, A., Liversedge, V., De Boer, R.H., Passos-Coelho, J.L., O'Reilly, S., Bertelli, G., Joffe, J., Brown, J.E., Wilson, C., Tercero, J.C., Jean-Mairet, J., Gomis, R., Cameron, D.

Volltext

AOSOP6 Results from the 2-year open-label extension treatment phase of a pivotal phase 3 study of denosumab in patients with breast cancer and bone metastases previously treated wi... von Stopeck, A.T, Lipton, A, Martín, M, Body, J-J, Paterson, A, Steger, G.G, Tonkin, K, de Boer, R.H, Fujiwara, Y, Yardley, D, Jassem, J, Takano, T, Solal-Céligny, P, Fan, M, Braun, A

Volltext

205P Pooled exploratory analysis of survival in patients (pts) with HR+/HER2- advanced breast cancer (ABC) and visceral metastases (mets) treated with ribociclib (RIB) + endocrine... von Yardley, D.A., Yap, Y.S., Azim, H.A., De Boer, R.H., Campone, M., Ring, A., De Laurentiis, M., O'Shaughnessy, J., Cortés, J., Chattar, Y., Thuerigen, A., Zarate, J.P., Nusch, A.

Volltext

VP5-2021: IMpower133: Gene expression (GE) analysis in long-term survivors (LTS) with ES-SCLC treated with first-line carboplatin and etoposide (CE) ± atezolizumab (atezo) von Liu, S.V., Mok, T.S.K., Mansfield, A.S., De Boer, R.H., Losonczy, G., Sugawara, S., Krzakowski, M.J., Smolin, A., Hochmair, M.J., Garassino, M.C., Gay, C.M., Heymach, J.V., Byers, L.A., McCleland, M., Nabet, B.Y., Morris, S., Adler, L., Shames, D., Reck, M.

Volltext

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial von Delaloge, S., Cella, D., Ye, Y., Buyse, M., Chan, A., Barrios, C.H., Holmes, F.A., Mansi, J., Iwata, H., Ejlertsen, B., Moy, B., Chia, S.K.L., Gnant, M., Smichkoska, S., Ciceniene, A., Martinez, N., Filipović, S., Ben-Baruch, N.E., Joy, A.A., Langkjer, S.T., Senecal, F., de Boer, R.H., Moran, S., Yao, B., Bryce, R., Auerbach, A., Fallowfield, L., Martin, M.

Volltext

412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in s... von Chu, Q.S, Kim, S.W, Ellis, P.M, Mileshkin, L, de Boer, R.H, Park, J.S, Pellas, T, Huang, F, Finckenstein, F. Graf, Dhar, A

Volltext

233P Real-world first-line (1L) treatment selection for Australian patients (pts) with hormone receptor-positive advanced breast cancer (HR+ ABC) von Wong, V., Baron-Hay, S.E., De Boer, R.H., Boyle, F., Collins, I.M., Cuff, K., Gately, L., Georgiou, C.L., Greenberg, S., Jude, E., Karki, B., Mok, K., Morton, C., Nottage, M.K., Rainey, N., Torres, J., Tung, I., Gibbs, P., Lok, S.W.

Volltext

9004 Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial von Vansteenkiste, J, Arrieta, O, Gottfried, M, Blackhall, F.H, Raats, J, Yang, C.H, Langmuir, P, Milenkova, T, Read, J, de Boer, R.H

Volltext

A Phase 2, Randomized, Double-Blind, Multicenter Trial of Denosumab in Combination with Chemotherapy As First-Line Treatment of Metastatic Non-Small Cell Lung Cancer von Spigel, D.R., Hirsch, F.R., De Boer, R.H., Natale, R., Crawford, J., Weiss, G.J., Glaspy, J., Feng, A., Braun, A., Jain, R.

Volltext

1330TiPA PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER TRIAL OF DENOSUMAB IN COMBINATION WITH CHEMOTHERAPY AS FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER von Spigel, D.R., Hirsch, F.R., De Boer, R.H., Natale, R., Crawford, J., Weiss, G.J., Glaspy, J., Feng, A., Braun, A., Jain, R.

Volltext

1513PRISK FACTORS FOR HYPOCALCEMIA IN PATIENTS WITH CANCER RECEIVING DENOSUMAB von Body, J., Bone, H.G., van Poznak, C., De Boer, R.H., Stopeck, A., Damião, R., Fizazi, K., Henry, D.H., Ibrahim, T., Lipton, A., Saad, F., Shore, N.D., Takano, T., Wang, H., Bracco, O.L., Balakumaran, A., Kostenuik, P.J.

Volltext

Risk Factors for Hypocalcemia in Patients with Cancer Receiving Denosumab von Body, J., Bone, H.G., van Poznak, C., De Boer, R.H., Stopeck, A., Damião, R., Fizazi, K., Henry, D.H., Ibrahim, T., Lipton, A., Saad, F., Shore, N.D., Takano, T., Wang, H., Bracco, O.L., Balakumaran, A., Kostenuik, P.J.

Volltext

Multimodality therapy in inflammatory breast cancer: Is there a place for surgery? von De Boer, R. H., Allum, W. H., Ebbs, S. R., Gui, G. P. H., Johnston, S. R. D., Sacks, N. P. M., Walsh, G., Ashley, S., Smith, I. E.

Volltext

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer von De Boer, R. H., Eisen, T. G., Ellis, P. A., Johnston, S. R. D., Walsh, G., Ashley, S., Smith, I. E.

Volltext

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) von Coleman, R.E, Collinson, M, Gregory, W, Marshall, H, Bell, R, Dodwell, D, Keane, M, Gil, M, Barrett-Lee, P, Ritchie, D, Bowman, A, Liversedge, V, De Boer, R.H, Passos-Coelho, J.L, O'Reilly, S, Bertelli, G, Joffe, J, Brown, J.E, Wilson, C, Tercero, J.C, Jean-Mairet, J, Gomis, R, Cameron, D

Volltext bestellen

Continuous infusional combination chemotherapy in inflammatory breast cancer: a phase II study von de Boer, R.H., Saini, A., Johnston, S.R.D., O'Brien, M.E.R., Ellis, P.A., Verrill, M.W., Prendiville, J.A., Walsh, G., Ashley, S., Smith, I.E.

Volltext

Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study von Botta, Michela, Tsonas, Anissa M, Pillay, Janesh, Boers, Leonoor S, Algera, Anna Geke, Bos, Lieuwe D J, Dongelmans, Dave A, Hollmann, Marcus W, Horn, Janneke, Vlaar, Alexander P J, Schultz, Marcus J, Neto, Ary Serpa, Paulus, Frederique, van Akkeren, Jesse P., Algera, Anna Geke, Algoe, Cheetel K., van Amstel, Rombout B., Baur, Onno L., van de Berg, Pablo, van den Berg, Alida E., Bergmans, Dennis C.J.J., van den Bersselaar, Dido I., Bertens, Freke A., Bindels, Alexander J.G.H., de Boer, Milou M., den Boer, Sylvia, Boers, Leonoor S., Bogerd, Margriet, Bos, Lieuwe D.J., Botta, Michela, Breel, Jennifer S., de Bruin, Hendrik, de Bruin, Sanne, Bruna, Caro L., Buiteman-Kruizinga, Laura A., Cremer, Olaf L., Determann, Rogier M., Dieperink, Willem, Dongelmans, Dave A., Franke, Hildegard S., Galek-Aldridge, Michal S., de Graaff, Mart J., Hagens, Laura A., Haringman, Jasper J., van der Heide, Sebastiaan T., van der Heiden, Pim L.J., Heijnen, Nanon F.L., Hiel, Stephan J.P., Hoeijmakers, Lotte L., Hol, Liselotte, Hollmann, Markus W., Hoogendoorn, Marga E., Horn, Janneke, van der Horst, Robrecht, Ie, Evy L.K., Ivanov, Dimitri P., Juffermans, Nicole, Kho, Eline, de Klerk, Eline S., Koopman-van Gemert, Ankie W.M.M., Koopmans, Matty, Kucukcelebi, Songul, Kuiper, Michael A., de Lange, Dylan W., van Mourik, Niels, Nijbroek, Sunny G.L.H., Onrust, Marisa, Oostdijk, Evelien A.N., Paulus, Frederique, Pennartz, Charlotte J., Pillay, Janesh, Pisani, Luigi, Purmer, Ilse M., Rettig, Thijs C.D., Roozeman, Jan-Paul, Schuijt, Michiel T.U., Schultz, Marcus J., Serpa Neto, Ary, Sleeswijk, Mengalvio E., Smit, Marry R., Spronk, Peter E., Stilma, Willemke, Strang, Aart C., Tsonas, Anissa M., Tuinman, Pieter R., Valk, Christel M.A., Veen-Schra, Felicia L., Veldhuis, Lars I., van Velzen, Patricia, van der Ven, Ward H., Vlaar, Alexander P.J., van Vliet, Peter, van der Voort, Peter H.J., van Welie, Louis, Wesselink, Henrico J.F.T., van der Wier-Lubbers, Hermien H., van Wijk, Bas, Winters, Tineke, Wong, Wing Yi, van Zanten, Arthur R.H.

Volltext

The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults von Sieswerda, Elske, Bax, Hannelore I, Hoogerwerf, Jacobien J, de Boer, Mark G. J, Boermeester, Marja, Bonten, Marc J. M, Dekker, Douwe, van Wijk, Roy Gerth, Juffermans, Nicole P, Kuindersma, Marnix, van der Linden, Paul D, Melles, Damian C, Pickkers, Peter, Schouten, Jeroen A, Rebel, Jasper R, van Zanten, Arthur R. H, Prins, Jan M, Wiersinga, W. Joost

Volltext

Successful Treatment of Severe Hyperammonaemia with Ultra-High Dose Continuous Veno-Venous Haemodiafiltration von Boer, Dirk P., Mourik, Sarah L., van den Hoogen, Martijn W.F., Langendonk, Janneke G., de Geus, Hilde R.H.

Volltext

Quercetin, but Not Its Glycosidated Conjugate Rutin, Inhibits Azoxymethane-Induced Colorectal Carcinogenesis in F344 Rats von Dihal, Ashwin A, Boer, Vincent C.J. de, Woude, Hester van der, Tilburgs, Chantal, Bruijntjes, Joost P, Alink, Gerrit M, Rietjens, Ivonne M.C.M, Woutersen, Ruud A, Stierum, Rob H

Volltext